A longitudinal study of CEACAM1 expression in melanoma disease progression

被引:17
作者
Zippel, Douglas [1 ,2 ]
Barlev, Hani [1 ]
Ortenberg, Rona [3 ]
Barshack, Iris [2 ,4 ]
Schachter, Jacob [2 ,3 ]
Markel, Gal [2 ,3 ,5 ]
机构
[1] Chaim Sheba Med Ctr, Dept Surg C, IL-52621 Tel Hashomer, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[3] Chaim Sheba Med Ctr, Ella Inst Melanoma, IL-52621 Tel Hashomer, Israel
[4] Chaim Sheba Med Ctr, Inst Pathol, IL-52621 Tel Hashomer, Israel
[5] Chaim Sheba Med Ctr, Talpiot Med Leadership Program, IL-52621 Tel Hashomer, Israel
关键词
CEACAM1; metastatic melanoma; immunotherapy; ELEVATED EXPRESSION; MALIGNANT-MELANOMA; ADHESION; LUNG; INHIBITION; ANTIBODY; PROTEIN; SAFETY; CELLS;
D O I
10.3892/or.2014.3703
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study characterized the carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) expression profile in a longitudinal study during melanoma progression, in lesions obtained from the same patients: a primary skin lesion, a lymph node and a distant metastasis. The present study is expected to increase our understanding of the expression patterns of CEACAM1 in melanoma development. We identified 20 patients who could be analyzed for CEACAM1 expression over the course of disease progression. The pathology blocks were cut, and two slides were generated for each specimen. One underwent standard hematoxylin and eosin (H&E) staining and a corresponding slide underwent immunohistochemical staining for the detection of CEACAM1. For 13 patients who were able to be followed up serially from primary lesion, lymph node and distant metastasis, a borderline significant increase in the staining of the membrane was noted (P=0.06). In contrast, there was no equivalent increase in cytoplasmic CEACAM1 in the same group of patients. For the cohort of 20 patients with primary and distant metastasis, a significant increase in the membrane staining was noted (P=0.026) and again, no equivalent significant increase in cytoplasmic staining was observed. We report that CEACAM1 expression increases along the course of disease development and progression of a patient. CEACAM1 represents a novel area of research which may have profound influence in future methods of harnessing cellular immunity to combat this disease. The results of the present study confirm that CEACAM1 is potentially an extremely useful target in arresting melanoma progression.
引用
收藏
页码:1314 / 1318
页数:5
相关论文
共 50 条
[31]   CEACAM1: A Novel Urinary Marker for Bladder Cancer Detection [J].
Tilki, Derya ;
Singer, Bernhard B. ;
Shariat, Shahrokh F. ;
Behrend, Andreas ;
Fernando, Malkanthi ;
Irmak, Ster ;
Buchner, Alexander ;
Hooper, Andrea T. ;
Stief, Christian G. ;
Reich, Oliver ;
Erguen, Sueleyman .
EUROPEAN UROLOGY, 2010, 57 (04) :648-654
[32]   Human CEACAM1 N-domain dimerization is independent from glycan modifications [J].
Dufrisne, Meagan Belcher ;
Swope, Nicole ;
Kieber, Marissa ;
Yang, Jeong-Yeh ;
Han, Ji ;
Li, Jason ;
Moremen, Kelley W. ;
Prestegard, James H. ;
Columbus, Linda .
STRUCTURE, 2022, 30 (05) :658-+
[33]   Neutrophils Infiltration in the Tongue Squamous Cell Carcinoma and Its Correlation with CEACAM1 Expression on Tumor Cells [J].
Wang, Ning ;
Feng, Yuanyong ;
Wang, Qingjie ;
Liu, Shaohua ;
Xiang, Lei ;
Sun, Mingxia ;
Zhang, Xiaoying ;
Liu, Guixiang ;
Qu, Xun ;
Wei, Fengcai .
PLOS ONE, 2014, 9 (02)
[34]   Neutrophil Extracellular Trap-Associated CEACAM1 as a Putative Therapeutic Target to Prevent Metastatic Progression of Colon Carcinoma [J].
Rayes, Roni F. ;
Vourtzoumis, Phil ;
Rjeily, Marianne Bou ;
Seth, Rashmi ;
Bourdeau, France ;
Giannias, Betty ;
Berube, Julie ;
Huang, Yu-Hwa ;
Rousseau, Simon ;
Camilleri-Broet, Sophie ;
Blumberg, Richard S. ;
Beauchemin, Nicole ;
Najmeh, Sara ;
Cools-Lartigue, Jonathan ;
Spicer, Jonathan D. ;
Ferri, Lorenzo E. .
JOURNAL OF IMMUNOLOGY, 2020, 204 (08) :2285-2294
[35]   CEACAM1 Negatively Regulates IL-1β Production in LPS Activated Neutrophils by Recruiting SHP-1 to a SYK-TLR4-CEACAM1 Complex [J].
Lu, Rongze ;
Pan, Hao ;
Shively, John E. .
PLOS PATHOGENS, 2012, 8 (04)
[36]   Carcinoembryonic Antigen Cell Adhesion Molecule-1 (CEACAM1) in Posterior Uveal Melanoma: Correlation with Clinical and Histological Survival Markers [J].
Khatib, Nur ;
Pe'er, Jacob ;
Ortenberg, Rona ;
Schachter, Jacob ;
Frenkel, Shahar ;
Markel, Gal ;
Amer, Radgonde .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (13) :9368-9372
[37]   TIM-3 and CEACAM1 do not interact in cis and in trans [J].
Linhares, Annika De Sousa ;
Kellner, Florian ;
Jutz, Sabrina ;
Zlabinger, Gerhard J. ;
Gabius, Hans-Joachim ;
Huppa, Johannes B. ;
Leitner, Judith ;
Steinberger, Peter .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2020, 50 (08) :1126-1141
[38]   Serum CEACAM1 Level Is Associated with Diagnosis and Prognosis in Patients with Osteosarcoma [J].
Yu, Haiying ;
Yu, Jian ;
Ren, Yanjun ;
Yang, Yun ;
Xiao, Xing .
PLOS ONE, 2016, 11 (04)
[39]   Tumor Angiogenesis Mediated by Myeloid Cells Is Negatively Regulated by CEACAM1 [J].
Lu, Rongze ;
Kujawski, Maciej ;
Pan, Hao ;
Shively, John E. .
CANCER RESEARCH, 2012, 72 (09) :2239-2250
[40]   CEACAM1 distribution and it's effects on angiogenesis and lymphangiogenesis in oral carcinoma [J].
Zhou, Cheng-Jun ;
Qu, Xun ;
Yang, Yong-Mei ;
Wang, Fu-Fang ;
Dong, Zuo-Qing ;
Wang, Cheng-Qin ;
Zhang, Xiao-Ying ;
Liu, Gui-Xiang ;
Wei, Feng-Cai ;
Sun, Shan-Zhen .
ORAL ONCOLOGY, 2009, 45 (10) :883-886